VANI — Vivani Medical, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1266806 ·
Last close
$1.36
Market Cap
$117.28M
52W High
$1.66
52W Low
$1.02
ADV30
714,862
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -6,817,000 | -6,780,000 | 42,353,000 | 19,749,000 | 23,268,000 |
| Dec 2025 | 0 | — | -6,810,000 | -6,633,000 | 39,393,000 | 16,232,000 | 23,663,000 |
| Sep 2025 | 0 | — | -6,725,000 | -6,530,000 | 25,046,000 | 2,628,000 | 23,737,000 |
| Jun 2025 | 0 | — | -7,462,000 | -7,144,000 | 28,905,000 | 6,794,000 | 23,995,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-25,353,000
Investing CF
$-1,171,000
Financing CF
$33,158,000
CapEx
$-1,171,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.42
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-155,313,000
Inventory
—
Receivables
$697,000
ST Investments
—
EBIT TTM
$-27,814,000
Pretax Income TTM
$-27,087,000
Interest Exp TTM
—
Analysts
3
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -27,556,000 | -26,609,000 | 39,393,000 | 23,663,000 | — | -24,320,000 |
| Dec 2024 | 0 | -24,677,000 | -23,486,000 | 41,561,000 | 23,951,000 | — | -20,786,000 |
| Dec 2023 | 0 | -26,965,000 | -25,652,000 | 45,797,000 | 25,036,000 | — | -23,699,000 |
| Dec 2022 | 0 | -21,241,000 | -13,889,000 | 51,130,000 | 6,822,000 | — | -18,787,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.35
Max Pain — expiry 2026-11-20
max pain strike: $1.00 · spot: $1.36 · call oi: 1,123 · put oi: 2
Expected Move to 2026-11-20:
±$0.70
(51.47%) —
implied range
$0.66 –
$2.06
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SKIN | SkinHealth Systems Inc. | $117.88M | $0.91 | — |
| STIM | Neuronetics, Inc. | $122.47M | $1.76 | — |
| RCEL | AVITA Medical, Inc. | $124.95M | $4.06 | — |
| GUTS | FRACTYL HEALTH, INC. | $125.76M | $0.79 | — |
| LAKE | LAKELAND INDUSTRIES INC | $108.86M | $11.03 | — |
News headlines (Yahoo Finance, 1h cache)
Novo Nordisk (CPSE:NOVO B) Could Be 13% Overvalued Following Its Vivani Deal
2026-07-09 16:12 · Yahoo
Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant
2026-07-08 11:11 · Yahoo
Novo Nordisk (CPSE:NOVO B) Teams Up With Vivani To Test A Semaglutide Implant
2026-07-07 19:18 · Yahoo
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
2026-07-07 11:35 · Yahoo
Vivani strikes reverse-merger agreement with ClearOne for BCI business
2026-07-03 11:40 · Yahoo
Why Did CLRO Stock Surge More Than 170% Today?
2026-07-02 17:53 · Yahoo
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
2026-07-02 12:00 · Yahoo
ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical
2026-07-02 12:00 · Yahoo
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
2026-06-26 11:30 · Yahoo
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
2026-06-25 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.